These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3742715)

  • 1. The activity of phosphohexose isomerase in primary breast carcinomas and response to chemotherapy in patients with metastatic disease.
    Mitchell I; Deshpande N; Millis R; Rubens RD
    Cancer Chemother Pharmacol; 1986; 17(3):289-91. PubMed ID: 3742715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic significance of serum phosphohexose isomerase in metastatic breast cancer].
    Paulick R; Caffier H
    Med Klin (Munich); 1987 May; 82(11):385-91. PubMed ID: 3600541
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship of glycolytic enzyme activities and response of breast cancer patients to chemotherapy: A preliminary report.
    Hilf R; Savlov ED; Rector WD; Wittliff JL
    Cancer; 1976 Aug; 38(2):695-700. PubMed ID: 974990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients.
    Yasasever V; Dinçer M; Camlica H; Duranyildiz D; Dalay N
    Eur J Gynaecol Oncol; 1997; 18(5):397-9. PubMed ID: 9378161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer.
    Baumann M; Kappl A; Lang T; Brand K; Siegfried W; Paterok E
    Cancer Invest; 1990; 8(3-4):351-6. PubMed ID: 2207761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme activity, acidic nuclear proteins, and prognosis in human breast cancer.
    Smith JA; King RJ; Meggitt BF; Allen LN
    Br Med J; 1970 Jun; 2(5711):698-701. PubMed ID: 5429652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The determination of phosphohexose isomerase in patients with cancer of breast and uterus. A comparison with other tests (author's transl)].
    Telesforo P; Rosenberg R
    Quad Sclavo Diagn; 1978 Sep; 15(3):365-72. PubMed ID: 37546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE VALUE OF SERUM PHOSPHOHEXOSE ISOMERASE AS AN INDEX OF METASTATIC BREAST CARCINOMA ACTIVITY.
    GRIFFITH MM; BECK JC
    Cancer; 1963 Aug; 16():1032-41. PubMed ID: 14050007
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue glycolytic enzymes in primary breast cancer patients receiving adjuvant chemotherapy.
    Spyratos F; Oglobine J; Lidereau R; Hacene K; Brault C; Desplaces A
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):21-7. PubMed ID: 3956556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phosphohexose isomerase in cyst fluids and effusions as a complement to cytological diagnosis].
    Geier G; Müller B
    Fortschr Med; 1983 Dec; 101(46):2146-50. PubMed ID: 6662466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavior of phosphohexose isomerase activity (PHI) in the serum, pleural effusions, and ascitic fluids of subjects with malignant hematologic diseases and tumors].
    Valguarnera G; Trippiedi MA
    Boll Soc Ital Biol Sper; 1977 Jan; 53(1-2):15-9. PubMed ID: 911471
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of the determination of serum phosphohexose isomerase in malignant neoplasms].
    Bruno GF; Failla G; Foti E; Marchese V
    Minerva Med; 1978 Mar; 69(12):749-56. PubMed ID: 643216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R; Caffier H; Paulick M
    Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical studies in breast carcinoma. 1. Serum phosphohexose isomerase, lactate dehydrogenase and its isoenzyme changes.
    Saravanan CS; Balasubramanian MK; Gopalakrishnan V; Govindarajulu P; Nanjunda Rao R
    Indian J Cancer; 1977 Mar; 14(1):38-41. PubMed ID: 885568
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum phosphohexose isomerase in cancer. II. As an index of tumor growth in metastatic carcinoma of the breast.
    BODANSKY O
    Cancer; 1954 Nov; 7(6):1200-26. PubMed ID: 13209520
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycolytic enzymes in human breast carcinoma cytosols: the influence of commonly used reference parameters.
    Oglobine J; Spyratos F; Lidereau R; Brault C; Desplaces A
    Cancer Detect Prev; 1985; 8(1-2):67-70. PubMed ID: 4064053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastases.
    Munjal D; Chawla PL; Lokich JJ; Zamcheck N
    Cancer; 1976 Apr; 37(4):1800-7. PubMed ID: 4219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum phosphohexose isomerase in cancer.
    Rao YN; Chakravorty M; Khanna NN
    Indian J Cancer; 1976 Dec; 13(4):361-6. PubMed ID: 1022683
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum phosphohexose isomerase levels in patients with head and neck cancer.
    Goel H; Kohli GS; Lal H
    J Laryngol Otol; 1986 May; 100(5):581-5. PubMed ID: 3701205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic changes in breast carcinoma. II. Phosphohexose isomerase and lactic dehydrogenase levels in serum.
    Maity CR; Burma DP
    Indian J Cancer; 1973 Sep; 10(3):356-60. PubMed ID: 4785884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.